PyInvesting

Market research

4559.TSE Zeria Pharmaceutical Co., Ltd

TSE JPY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
85B
P/E ratio
10.31
Analyst target
2200
Dividend yield
2.5%
Beta
0.06

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Zeria Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 2.5% above its 200 day moving average.

From a valuation standpoint, the stock is 97.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.

Zeria Pharmaceutical Co., Ltd's total revenue sank by 2.6% to $16B since the same quarter in the previous year.

Its net income has increased by 107.1% to $2B since the same quarter in the previous year.

Based on the above factors, Zeria Pharmaceutical Co., Ltd gets an overall score of 3/5.